Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections
Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections in Patients With Cancer and Hematologic Diseases
Sponsor: Aarhus University Hospital
Listed as NCT05376566, this NA trial focuses on Central Line-associated Bloodstream Infection (CLABSI) and remains actively recruiting participants. Sponsored by Aarhus University Hospital, it has been updated 7 times since 2022, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Feb 2026 — Present [monthly]
Recruiting NA
-
Oct 2025 — Feb 2026 [monthly]
Recruiting NA
-
Sep 2024 — Oct 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jul 2022 — Nov 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2022 — Jul 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aarhus University Hospital
- Odense University Hospital
- Rigshospitalet, Denmark
For direct contact, visit the study record on ClinicalTrials.gov .